Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and offer the covid-19 vaccine to people with (a) blood cancer and (b) and other blood disorders such as sickle cell and thalassemia.

Priority group six includes all those who are defined as clinically vulnerable and at higher risk of serious illness from COVID-19. People with blood cancer and other blood disorders such as sickle cell and thalassemia are included in this definition. Many people with these disorders may be defined as clinically extremely vulnerable (CEV). Those who are CEV are included in priority group four. Those in priority group four should already have been offered the vaccine.